Appropriate dose of etoposide with cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for adult patients with acute leukemia or non-Hodgkin's lymphoma.

被引：0
|
作者：
Mori, A
Tanaka, J
Hashino, S
Kahata, K
Toyoshima, N
Ota, S
Yamamoto, Y
Kobayashi, S
Asaka, M
Imamura, M
机构：
[1] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hematol, Sapporo, Hokkaido, Japan
[2] Hokkaido Univ, Grad Sch Med, Dept Hematol Oncol, Sapporo, Hokkaido, Japan
[3] Hokkaido Univ, Grad Sch Med, Div Transfus Surv, Sapporo, Hokkaido, Japan
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5061
引用
收藏
页码：305B / 305B
页数：1
相关论文
共 50 条
  • [11] Busulfan, cyclophosphamide and total body irradiation as conditioning for allogeneic bone marrow transplantation for acute and chronic myeloid leukemia
    N Hirabayashi
    S Goto
    M Ishii
    M Yuge
    A Mitsuma
    N Noda
    Bone Marrow Transplantation, 1998, 21 : 1079 - 1083
  • [12] CD6 depleted allogeneic and syngeneic bone marrow transplantation (BMT) for non-Hodgkin's lymphoma.
    Soiffer, RJ
    Neuberg, D
    Freedman, AS
    Alyea, EP
    Fisher, DC
    BartlettPandite, L
    Gribben, J
    Schlossman, RL
    Freeman, A
    Anderson, KC
    Nadler, LM
    Ritz, J
    BLOOD, 1996, 88 (10) : 2719 - 2719
  • [13] Allogeneic bone marrow transplantation (BMT) for acute lymphoblastic leukemia (ALL) patients conditioned with high dose methylprednisolone, total body irradiation and cyclophosphamide.
    Macedo, MCMA
    Silva, RL
    Ostronoff, M
    Medeiros, RSS
    Massumoto, C
    Zambon, E
    Loterio, H
    Dorlhiacllacer, PE
    Chamone, DAF
    Dulley, F
    BLOOD, 1995, 86 (10) : 3808 - 3808
  • [14] High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma
    Law, Lisa Y.
    Horning, Sandra J.
    Wong, Ruby M.
    Johnston, Laura J.
    Laport, Ginna G.
    Lowsky, Robert
    Shizuru, Judith A.
    Blume, Karl G.
    Negrin, Robert S.
    Stockerl-Goldstein, Keith E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (07) : 703 - 711
  • [15] Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin’s disease and non-Hodgkin’s lymphoma
    EJ Dann
    CK Daugherty
    RA Larson
    Bone Marrow Transplantation, 1997, 20 : 369 - 374
  • [16] Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma
    Dann, EJ
    Daugherty, CK
    Larson, RA
    BONE MARROW TRANSPLANTATION, 1997, 20 (05) : 369 - 374
  • [17] Leukemia following low-dose total body irradiation and chemotherapy for non-Hodgkin's lymphoma
    Travis, LB
    Weeks, J
    Curtis, RE
    Chaffey, JT
    Stovall, M
    Banks, PM
    Boice, JD
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) : 565 - 571
  • [18] Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma
    Brown, JR
    Yeckes, H
    Friedberg, JW
    Neuberg, D
    Kim, H
    Nadler, LM
    Freedman, AS
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (10) : 2208 - 2214
  • [19] Allogeneic bone marrow transplantation (BMT) for children with leukemia: Cytoreduction with fractionated total body irradiation (fTBI), high-dose etoposide (VP) and cyclophosphamide (CY).
    Duerst, RE
    Horan, J
    Constine, LS
    Rapaport, AP
    Abboud, CN
    Packman, CH
    Rowe, JM
    Liesveld, JL
    BLOOD, 1997, 90 (10) : 4157 - 4157
  • [20] Busulfan vs total body irradiation combined with cyclophosphamide as conditioning for autologous or allogeneic bone marrow transplantation in patients with Acute Leukemia.
    Labopin, M
    Ringden, O
    Mandelli, F
    Tura, S
    Iriondo, A
    Haas, R
    Gluckman, E
    Gorin, NC
    BLOOD, 1995, 86 (10) : 361 - 361
12345